Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency
https://doi.org/10.35754/0234-5730-2021-66-1-79-87
Abstract
Introduction. Among the most common congenital coagulopathies are haemophilia and Von Willebrand disease. These illnesses are often mimicked by orphan hereditary coagulopathies, including combined coagulation factor V and VIII deficiency.
Aim — description of a clinical presentation, hampered diagnosis and choice of haemostatic therapy in a surgical patient with combined blood coagulation factor V and VIII deficiency.
Main findings. We describe a clinical case of congenital combined factor V and VIII deficiency and detail the aetiology, frequency, localisation and intensity of haemorrhages. Comorbidity and surgical indications are demonstrated to require an inter-specialty medical involvement.
About the Authors
E. V. YakovlevaRussian Federation
Elena V. Yakovleva, Cand. Sci. (Med.), Researcher, Department of Coagulopathy
I. V. Efimov
Russian Federation
Igor V. Efimov, Surgeon
A. I. Kostin
Russian Federation
Alexandr I. Kostin, Cand. Sci. (Med.), Head of the Department of Clinical Production Transfusiology and Gravitational Blood Surgery
125167, Moscow
A. M. Gasanov
Russian Federation
Ali M. Gasanov, Cand. Sci. (Med.), Senior Researcher, Department of Emergency Surgery, Endoscopy and Intensive Care
125167, Moscow
M. Kh. Azimova
Russian Federation
Mukhaiekhon Kh. Azimova, Cand. Sci. (Med.), Transfusiologist, Department of Clinical Production Transfusiology and Gravitational Blood Surgery
125167, Moscow
E. B. Orel
Russian Federation
Elena B. Orel, Leader of the Hemostasis Pathology Group, Central Clinical Diagnostic Laboratory
P. S. Lavrova
Russian Federation
Polina S. Lavrova, Physician, Central Clinical Diagnostic Laboratory
N. I. Konyashina
Russian Federation
Nadezhda I. Konyashina, Cand. Sci. (Med.), Physician, Express Laboratory, Department of Intensive Care
V. L. Surin
Russian Federation
Vadim L. Surin, Senior Researcher, Laboratory of Genetic Engineering
O. S. Pshenichnikova
Russian Federation
Olesya S. Pshenichnikova, Cand. Sci. (Biol.), Senior Researcher, Laboratory of Genetic Engineering
N. V. Sats
Russian Federation
Nataliya V. Sats, Cand. Sci. (Biol.), Senior Researcher, Laboratory of Hematopoietic Physiology
125167, Moscow
N. I. Zozulya
Nadezhda I. Zozulya, Dr. Sci. (Med.), Head of the Department of Coagulopathy
125167, Moscow
References
1. Gupta S., Acharya S., Roberson C. et al. Potential of the Community Counts registry to characterize rare bleeding disorders. Haemophilia. 2019; 25(6): 1045– 50. DOI: 10.1111/hae.13847.
2. Shapiro А. The use of prophylaxis in the treatment of rare bleeding disorders. Thromb Res. 2019; 19: S0049-3848(19)30297-X. DOI: 10.1016/j.thromres.2019.07.014.
3. Spreafi co М., Peyvandi F. Combined FV and FVIII deficiency. Haemophilia. 2008; 14(6): 1201–8. DOI: 10.1111/j.1365-2516.2008.01845.x.
4. Zhang B., McGee B., Yamaoka J. Combined deficiency of factor V and factor VIII is due to mutation in either LMAN1 or MCFD2. Blood. 2006; 107 (5): 1903–7. DOI: 10.1182/blood-2005-09-3620.
5. Russo R, Esposito М, Iolascon А. Inherited hematological disorders due to defects in coat protein (COP) II complex. Am J Hematol. 2013; 88(2): 135–40. DOI: 10.1002/ajh.23292.
6. Zhang B, Cunningham М., Nichols W. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet. 2003; 34(2): 220–5. DOI: 10.1038/ng1153.
7. Zheng C., Liu H., Zhou J., et al. EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII. Blood. 2010; 115(5): 1081–7. DOI: 10.1182/blood-2009-09-241877.
8. Kashoub M., Al-Amri U., Saifudeen А. Combined factor V and VIII deficiency. Oman Med J. 2018; 33(3): 268. DOI: 10.5001/omj.2018.51.
9. Kesireddy S. Recurrent ruptured hemorrhagic corpus luteal cyst in a known case of combined deficiency of factor V and VIII. J Obstet Gynaecol India. 2018; 68(3): 229–231. DOI: 10.1007/s13224-017-1028-x.
10. Ogawa Y., Yanagisawa К., Uchiyama U. Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma. Rinsho Ketsueki. 2018; 59(4): 383–8. DOI: 10.11406/rinketsu.59.383.
11. Fogarty H., Doyle M., Campbell R. Management of combined factor V and factor VIII deficiency in pregnancy. J Obstet Gynaecol. 2019; 39(2): 271–2. DOI: 10.1080/01443615.2018.1448766.
12. Spiliopoulos D., Kadir R. Congenital factor V and VIII deficiency in women: A systematic review of literature and report of two new cases. Blood Coagul Fibrinolysis. 2016; 27(3): 237–41. DOI: 10.1097/MBC.0000000000000407.
13. Peyvandi F., Tuddenham Е., Akhtari А., et al. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol. 1998; 100(4): 773–6.
14. Jain S., Acharya S.S. Management of rare coagulation disorders in 2018. Transfus Apher Sci. 2018; 57(6): 705–12. DOI: 10.1016/j.transci.2018.10.009.
15. Franchini M., Marano G., Pupella S. Rare congenital bleeding disorders. Ann Transl Med. 2018; 6(17): 331. DOI: 10.21037/atm.2018.08.34.
16. Howard C., Lipe B. Combined deficiency of factor V and factor VIII: Management during cardiothoracic surgery. Blood Coagul Fibrinolysis. 2017; 28(3): 267–8. DOI: 10.1097/MBC.0000000000000574.
17. Patel A., Liu H., Lager R., et al. Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1. Haemophilia. 2013; 19(4): 607–10. DOI: 10.1111/hae.12128.
18. Brown L., Tilzer L., Plapp F. Factor V and VIII deficiency treated with therapeutic plasma exchange prior to redo mitral valve replacement. J Clin Apher. 2017; 32(3): 196–9. DOI: 10.1002/jca.21478.
19. Ates I., Kaplan M., Tokgoz G. Combined factor V and VIII defi ciency in a young woman with abundant bleeding after tooth extraction. Blood Res. 2016; 51(1): 67–8. DOI: 10.5045/br.2016.51.1.67.
20. Mumford А., Ackroyd S., Alikhan R. Guideline for the diagnosis and management of the rare coagulation disorders: A United Kingdom Haemophilia Centre Doctors’ Organization Guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014; 167(3): 304–26. DOI: 10.1111/bjh.13058.
21. Bux J. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang. 2011; 100(1): 122–8. DOI: 10.1111/j.1423-0410.2010.01392.x.
22. Manno M., Piccoli M., Frazzoni M., et al. Endoscopic and surgical management of Zenker’s diverticulum: New approaches. In: Conigliaro R., Frazzoni M. (Eds) Diagnosis and endoscopic management of digestive diseases. Springer. 2017: 179–87. DOI: 10.1007/978-3-319-42358-6_11.
23. Hussain Т., Maurer J., Lang S. Pathophysiology, diagnosis and treatment of Zenker’s diverticulum HNO. 2017; 65(2): 167–76. DOI: 10.1007/s00106-016-0302-z.
24. Huang J.N., Koerper M.A. Factor V deficiency: A concise review. Haemophilia. 2008; 14(6): 1164–9. DOI: 10.1111/j.1365-2516.2008.01785.x.
Review
For citations:
Yakovleva E.V., Efimov I.V., Kostin A.I., Gasanov A.M., Azimova M.Kh., Orel E.B., Lavrova P.S., Konyashina N.I., Surin V.L., Pshenichnikova O.S., Sats N.V., Zozulya N.I. Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency. Russian journal of hematology and transfusiology. 2021;66(1):79-87. (In Russ.) https://doi.org/10.35754/0234-5730-2021-66-1-79-87